Immunologic and chemotherapeutic parameters in a model breast tumor system.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D007111:Immunity, Cellular; D007167:Immunotherapy; D007962:Leukocytes / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D051379:Mice; D012756:Sheep / Q000276:immunology
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents